RESMED INC — Director's Dealing 2019

Aug 15, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2019-08-12

Reporting Person: Farrell Michael J. (Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-08-12	ResMed Common Stock	M	6651	$43.63	Acquired	292988	Direct
2019-08-12	ResMed Common Stock	S	6651	$132.35	Disposed	286337	Direct
2019-08-14	ResMed Common Stock	A	17987	—	Acquired	304324	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-08-12	ResMed Common Stock Options	$43.63	M	6651	Disposed	2020-03-01	ResMed Commmon Stock (6651)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
ResMed Common Stock	10340	Indirect

Footnotes

F1: The transaction was conducted under a Rule 10b5-1 plan.

F2: This transaction was executed in multiple trades at prices ranging from $131.35 to 132.86. The price reported above reflects the weighted average sale price.

F3: Represents performance-based restricted stock units granted on November 14, 2018. The shares were earned on August 14, 2019, when the compensation committee certified that the performance metrics were met.

F4: Represents date options first became exercisable. Options vest 1/3 per year.